The current human and back‐translational MRI investigations were based on the hypotheses that the clinical PMS phenotype might be influenced by microstructural pathologies in the brains of these participants that can be attributed to SHANK3 deficiency and should therefore be reproduceable in our Shank3 KO mouse model. This evidence concerns the gene SHANK3 and premenstrual tension.